{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T10:10:08Z","timestamp":1741774208990,"version":"3.38.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Nursing"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jvn.2025.01.004","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T20:08:53Z","timestamp":1739045333000},"page":"55-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of training on satisfaction and anxiety levels in stroke patients receiving warfarin treatment"],"prefix":"10.1016","volume":"43","author":[{"given":"Fadime","family":"Aynal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5668-3694","authenticated-orcid":false,"given":"Selda","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvn.2025.01.004_bib0001","article-title":"Atrial fibrillation and stroke: state-of-the-art and future directions","volume":"49","author":"Elsheikha","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jvn.2025.01.004_bib0002","unstructured":"Nazliel B., Arlier Z. Acute ischemic stroke diagnosis and treatment guideline (version 1.0) ministry of health Turkey, research, Development and health technology evaluation department 2020. ISBN: 978-975-590-745-1."},{"issue":"2","key":"10.1016\/j.jvn.2025.01.004_bib0003","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1076029615600792","article-title":"Comparison of changes in anxietyand depression level between dabigatran and warfarin use in patients with atrial fibrillation","volume":"23","author":"Turker","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"10.1016\/j.jvn.2025.01.004_bib0004","first-page":"77","article-title":"Anticoagulant usage for mechanic cardiac valve replaced patients and warfarin resistance","volume":"15","author":"Salman","year":"2015","journal-title":"Ankara Med J"},{"key":"10.1016\/j.jvn.2025.01.004_bib0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2018.01.024","article-title":"Effect of increased time in the therapeutic range on atrial fibrillation outcomes within a centralized anticoagulation service","volume":"163","author":"Phelpsa","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvn.2025.01.004_bib0006","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/rth2.12328","article-title":"Is the time in therapeutic range on coumarins predicted by previous time in therapeutic range?","volume":"4","author":"Miert","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jvn.2025.01.004_bib0007","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2020.04.001","article-title":"Anticoagulation control in different ethnic groups receiving vitamin K antagonist therapy for stroke prevention in atrial fibrillation","volume":"192","author":"Zulkiflya","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvn.2025.01.004_bib0008","first-page":"328","article-title":"Comparison of warfarin use in terms of efficacy and safety in two different polyclinics","volume":"18","author":"K\u0131l\u0131\u00e7","year":"2017","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.jvn.2025.01.004_bib0009","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4103\/njcp.njcp_608_18","article-title":"Warfarin therapy adherence and health-related quality of life among patients using warfarin in Saudi Arabia","volume":"23","author":"Al-Saikhan","year":"2020","journal-title":"Niger J Clin Pract"},{"issue":"3","key":"10.1016\/j.jvn.2025.01.004_bib0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.14744\/SEMB.2019.76993","article-title":"Determining INR awareness of the patients who use warfarin and rates of achieving the target dosage","volume":"54","author":"Demir","year":"2020","journal-title":"Med Bull Sisli Etfal Hosp"},{"issue":"4","key":"10.1016\/j.jvn.2025.01.004_bib0011","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5606\/tgkdc.dergisi.2014.9664","article-title":"Validity and reliability of the Turkish version of the Duke anticoagulant satisfaction scale","volume":"22","author":"Y\u0131ld\u0131r\u0131m","year":"2014","journal-title":"Turk J Thorac Cardiovascul Surg"},{"issue":"1","key":"10.1016\/j.jvn.2025.01.004_bib0012","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jsps.2017.11.010","article-title":"Association between satisfaction with and adherence to warfarin therapy on the control of international normalized ratio: a hospital-based study in Saudi Arabia","volume":"26","author":"Balkhi","year":"2018","journal-title":"Saud Pharm J"},{"issue":"4","key":"10.1016\/j.jvn.2025.01.004_bib0013","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.thromres.2014.01.013","article-title":"Comparingpatient-leveland site-level anticoagulation control as predictors of adverseevents","volume":"133","author":"Cancino","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvn.2025.01.004_bib0014","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1186\/s12889-019-7370-4","article-title":"Impact of an electronic medium delivery of warfarin education in a low income, minority outpatient population: a pilot intervention study","volume":"19","author":"Heinrich","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jvn.2025.01.004_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1371\/journal.pone.0074037","article-title":"Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial","volume":"8","author":"Clarkesmith","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.jvn.2025.01.004_bib0016","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.apnr.2016.10.008","article-title":"The effect of nurse-led care on stability time in therapeutic range of INR in ischemic stroke patients receiving warfarin","volume":"33","author":"Amiri","year":"2017","journal-title":"Appl Nurs Res"},{"key":"10.1016\/j.jvn.2025.01.004_bib0017","series-title":"Discontinuous State \/Trait Anxiety Inventory Handbook","first-page":"1","author":"\u00d6ner","year":"1985"},{"key":"10.1016\/j.jvn.2025.01.004_bib0018","unstructured":"Turkish Cardiology Association, Valvular Diseases Working Group. Guidelines for patients using anticoagulant medication (coumadin), 2012. http:\/\/file.tkd.org.tr\/kilavuzlar\/Coumadin_kilavuz.pdf Eri\u015fim tarihi: 1 \u015eubat 2018."},{"issue":"7","key":"10.1016\/j.jvn.2025.01.004_bib0019","first-page":"474","article-title":"Comparison of health-relatedquality of life among patients using novel oral anticoagulants or warfarin for non-valvular atrial fibrillation","volume":"16","author":"Balc\u0131","year":"2016","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.jvn.2025.01.004_bib0020","first-page":"9","article-title":"Evaluation of time in therapeuticrange (ttr) in patients with non-valvular atrial fibrillation receiving treatment with warfarin in tehran, \u0131ran: a cross-sectional study","volume":"10","author":"Farsad","year":"2016","journal-title":"J Clin Diagnost Res"},{"key":"10.1016\/j.jvn.2025.01.004_bib0021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1371\/journal.pone.0188482","article-title":"The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: a systematic review and meta-regression analysis","volume":"12","author":"Vestergaard","year":"2017","journal-title":"PloS one"},{"issue":"2","key":"10.1016\/j.jvn.2025.01.004_bib0022","doi-asserted-by":"crossref","first-page":"240","DOI":"10.12669\/pjms.342.14216","article-title":"Effects of structured patient education on knowledge level and INR control of patients receiving warfarin: randomized controlled trial","volume":"34","author":"Baysal","year":"2018","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.jvn.2025.01.004_bib0023","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/ijpp.12148","article-title":"Anticoagulation management by community pharmacists in New Zealand: an evaluation of a collaborative model in primary care","volume":"23","author":"Harrison","year":"2015","journal-title":"Int J Pharm Pract"},{"issue":"4","key":"10.1016\/j.jvn.2025.01.004_bib0024","first-page":"266","article-title":"Hospital pharmacist intervention improves the quality indicator of warfarin control: a retrospective cohort study","volume":"64","author":"Taesong","year":"2017","journal-title":"J Med Invest"},{"key":"10.1016\/j.jvn.2025.01.004_bib0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1477-7525-9-91","article-title":"Quality of life analysis of patients in chronic use of oral anticoagulant: an observational study","volume":"9","author":"Almeida","year":"2011","journal-title":"Health Qual Life Outcome"},{"issue":"1","key":"10.1016\/j.jvn.2025.01.004_bib0026","first-page":"43","article-title":"Examination of the satisfaction level of elderly patients with oral anticoagulant use","volume":"2","author":"Mert","year":"2016","journal-title":"Clin J Intern Med Nurs Spec Top"},{"issue":"1","key":"10.1016\/j.jvn.2025.01.004_bib0027","first-page":"568","article-title":"The satisfaction levels of patients using anticoagulants","volume":"10","author":"Y\u0131ld\u0131z","year":"2017","journal-title":"Int J Caring Sci"},{"issue":"4","key":"10.1016\/j.jvn.2025.01.004_bib0028","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.thromres.2014.01.002","article-title":"Knowledge, satisfaction, and concerns regarding warfarin therapy and their association with warfarin adherence and anticoagulation control","volume":"133","author":"Wanga","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvn.2025.01.004_bib0029","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2147\/PPA.S152109","article-title":"Satisfaction with oral anticoagulants in patients with atrial fibrillation","volume":"12","author":"Su\u00e1rez Fern\u00e1ndez","year":"2018","journal-title":"Patient Prefer Adheren"},{"issue":"11","key":"10.1016\/j.jvn.2025.01.004_bib0030","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.cjco.2021.06.015","article-title":"Satisfaction with oral anticoagulants among patients with atrial fibrillation: a prospective observational study","volume":"3","author":"Salmasi","year":"2021","journal-title":"CJC Open"},{"issue":"4","key":"10.1016\/j.jvn.2025.01.004_bib0031","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/europace\/eut286","article-title":"The effect of a nurse-led integrated chronic care approach on quality of life in patients with atrial fibrillation","volume":"16","author":"Hendriks","year":"2014","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.jvn.2025.01.004_bib0032","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007814","article-title":"Anxiety, depression, and adverse clinical outcomes in patients with atrial fibrillation starting warfarin: cardiovascular research network WAVE Study","volume":"7","author":"Baumgartner","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.jvn.2025.01.004_bib0033","first-page":"568","article-title":"Evaluation of depression and anxiety levels and quality of life in patients using warfarin or new oral anticoagulants due to prophylaxis of stroke","volume":"8","author":"Demiry\u00fcrek","year":"2018","journal-title":"Sakarya Med J"}],"container-title":["Journal of Vascular Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1062030325000044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1062030325000044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T09:29:58Z","timestamp":1741771798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1062030325000044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1062030325000044"],"URL":"https:\/\/doi.org\/10.1016\/j.jvn.2025.01.004","relation":{},"ISSN":["1062-0303"],"issn-type":[{"type":"print","value":"1062-0303"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of training on satisfaction and anxiety levels in stroke patients receiving warfarin treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvn.2025.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Vascular Nursing, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}